Skip to main content
Primo Nutraceuticals Inc. logo

Primo Nutraceuticals Inc. — Investor Relations & Filings

Ticker · BUGVF ISIN · CA74167D2041 CSE Real estate activities
Open in API
Filings indexed 201 across all filing types
Latest filing 2020-02-27 Regulatory Filings
Country CA Canada
Listing CSE BUGVF

About Primo Nutraceuticals Inc.

https://www.primonutraceuticals.com

Primo Nutraceuticals Inc. is an investment and real estate development company dedicated to the cannabis cultivation sector. The company provides strategic capital and funding to support the growth in the production, processing, retail, and branding of cannabis and non-cannabis related products. Core operations include the ownership and development of commercial real estate properties, offering built-out turnkey solutions tailored for cannabis cultivation facilities. Furthermore, Primo Nutraceuticals is engaged in medicinal and botanical manufacturing, and the direct production, processing, and branding of cannabis and related goods.

Recent filings

Filing Released Lang Actions
AB form 13-501F2 (class 2 reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a management certification related to Form 13-501F2 for Class 2 Reporting Issuers, submitted to the Alberta Securities Commission. It includes certification by an officer of the reporting issuer regarding the completeness and accuracy of the information provided. The content is primarily a certification statement and fee calculation rather than a full financial report or detailed financial statements. The document length is short (1946 characters) and it does not contain substantive financial data or analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a certification and submission form rather than a full report or announcement of a report.
2020-02-27 English
ON form 13-502F2 (class 2 reporting Issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F2 for Class 2 Reporting Issuers concerning a Participation Fee submitted to the Ontario Securities Commission. It contains officer certification statements and financial data used for fee calculation but does not present a full financial report or detailed analysis. The primary purpose is certification and regulatory compliance rather than a comprehensive financial report. According to the Certification Rule, documents primarily consisting of officer certifications or attestations, even if referencing financial data, should be classified as Regulatory Filings (RNS).
2020-02-27 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document contains detailed financial statements for Primo Nutraceuticals Inc. for the years ended July 31, 2019 and 2018. It includes an Independent Auditors' Report, Statements of Financial Position, Statements of Loss and Comprehensive Loss, Statements of Changes in Shareholders' Deficiency, and Statements of Cash Flows. The presence of comprehensive financial data, notes to the financial statements, and an auditor's opinion indicates this is a full annual financial report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. The fiscal period covered is a full year, consistent with an Annual Report. Therefore, the appropriate classification is Annual Report (10-K). FY 2019
2020-02-27 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a corporate update announcing the resignation of a board director and audit committee member. It mentions the upcoming filing of annual financial statements and MD&A for the year ended July 31, 2019, but does not contain the financial statements or detailed financial data itself. The document is short (2042 characters) and serves as an announcement rather than the actual report. It also references compliance with regulatory guidelines and management cease trade order but does not provide audit details or financial results. Therefore, it fits best under Board/Management Information (MANG) as it primarily announces a change in the company's board of directors.
2020-01-03 English
Material change report - English.pdf
Regulatory Filings
2019-11-29 English
News release - English.pdf
Regulatory Filings
2019-11-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.